1194550-67-8 Usage
General Description
The chemical ((S)-benzyl 2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-methylsulfonyl)phenyl)propanoate is a complex compound that contains benzofuran, tetrahydroisoquinoline, and phenyl groups. It is a propanoate ester with a benzyl moiety attached to the main structure. The compound also contains chlorine atoms and a methylsulfonyl group. The presence of carbonyl and carboxamide groups suggests potential interactions with proteins and other biological molecules. ((S)-benzyl 2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-methylsulfonyl)phenyl)propanoate likely possesses pharmacological properties and may be used in medicinal chemistry or drug design due to its complex structure and potential biological activity.
Check Digit Verification of cas no
The CAS Registry Mumber 1194550-67-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,4,5,5 and 0 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1194550-67:
(9*1)+(8*1)+(7*9)+(6*4)+(5*5)+(4*5)+(3*0)+(2*6)+(1*7)=168
168 % 10 = 8
So 1194550-67-8 is a valid CAS Registry Number.
1194550-67-8Relevant articles and documents
PROCESS FOR PREPARATION OF LIFITEGRAST
-
Paragraph 0221, (2019/04/11)
The present invention relates to a process for the preparation of lifitegrast, a compound of formula I, the process comprising deprotecting a compound of formula III using a Lewis acid. The present invention also relates to lifitegrast organic amine salt, a compound of formula II, process for its preparation and conversion thereof to lifitegrast.
LFA-1 INHIBITOR AND POLYMORPH THEREOF
-
, (2014/02/16)
Methods of preparation and purification of a compound, intermediates thereof, a polymorph thereof, and related compounds are disclosed. Formulations and uses thereof in the treatment of LFA -1 mediated diseases are also disclosed.
